IL10RB was predicted to be significantly upregulated in individuals susceptible to COVID-19 hospitalization, with downregulation predicted to significantly antagonize the polygenetically driven gene expression differences associated with COVID-19 hospitalization (Supplementary Fig. 5). Here, IL10RB is linked to COVID-19.